Once-weekly exenatide in type 2 diabetes

被引：0
|
作者：
Parmar, Dinesh M. [1 ]
Jadav, Shilpa P. [1 ]
机构：
[1] MP Shah Med Coll, Dept Pharmacol, Jamnagar, Gujarat, India
来源：
INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES | 2011年 / 31卷 / 02期
关键词：
OPEN-LABEL;
D O I：
10.1007/s13410-011-0018-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：121 / 122
页数：2
相关论文
共 50 条
  • [41] Once-Weekly Exenatide: An Extended-Duration Glucagon-Like Peptide Agonist for the Treatment of Type 2 Diabetes Mellitus
    Minze, Molly G.
    Klein, Mary S.
    Jernigan, Michelle J.
    Wise, Stephen L.
    Fruge, Kristian
    PHARMACOTHERAPY, 2013, 33 (06): : 627 - 638
  • [42] MODELING HEALTH AND ECONOMIC OUTCOMES ASSOCIATED WITH EXENATIDE ONCE-WEEKLY VERSUS INSULIN AND PIOGLITAZONE TREATMENT FOR TYPE-2 DIABETES
    Gaebler, J. A.
    Soto-Campos, G.
    Alperin, P. E.
    Hoogwerf, B. J.
    Wintle, M.
    Maggs, D.
    Han, J.
    Blickensderfer, A.
    Pencek, R.
    Bruhn, D.
    Peskin, B. R.
    VALUE IN HEALTH, 2011, 14 (03) : A91 - A91
  • [43] Once-weekly Insulin Icodec: An emerging treatment option for type 2 Diabetes
    Zahra, Rubab
    Tariq, Fasiha
    Ahmed, Mushood
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2024, 74 (08) : 1583 - 1583
  • [44] Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment
    Suzuki, Yuya
    Zhao, Tianchen
    Tsubokura, Masaharu
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (08):
  • [45] Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment
    Rosenstock, Julio
    Bajaj, Harpreet S.
    Janez, Andrej
    Silver, Robert
    Begtrup, Kamilla
    Hansen, Melissa V.
    Jia, Ting
    Goldenberg, Ronald
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (22): : 2107 - 2116
  • [46] Efficacy and safety of once-weekly semaglutide vs exenatide ER after 56 Weeks in subjects with type 2 diabetes (SUSTAIN 3)
    Ahmann, Andrew
    Capehorn, Matthew
    Charpentier, Guillaume
    Dotta, Francesco
    Henkel, Elena
    Lingvay, Ildiko
    Holst, Anders Gaarsdal
    Annett, Miriam
    Aroda, Vanita
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S51 - S51
  • [47] Safety and Efficacy of Once-Weekly Exenatide Compared With Insulin Glargine Titrated to Target in Patients With Type 2 Diabetes Over 84 Weeks
    Diamant, Michaela
    Van Gaal, Luc
    Stranks, Stephen
    Guerci, Bruno
    MacConell, Leigh
    Haber, Harry
    Scism-Bacon, Jamie
    Trautmann, Michael
    DIABETES CARE, 2012, 35 (04) : 683 - 689
  • [48] Effect of Exenatide Once-Weekly on Clinical Outcomes in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease: Insights From the EXSCEL Trial
    Mentz, Robert J.
    Bethel, M. Angelyn
    Thompson, Vivian P.
    Lokhnygina, Yuliya
    Buse, John B.
    Chan, Julian C.
    Choi, Jasmine
    Gustavson, Stephanie M.
    Iqbal, Nayyar
    Maggioni, Aldo P.
    Marso, Steven P.
    Ohman, Peter
    Pagidipati, Neha J.
    Poulter, Neil
    Ramachandran, Ambady
    Zinman, Bernard
    Holman, Rury R.
    Hernandez, Adrian F.
    CIRCULATION, 2017, 136 (24) : E455 - E455
  • [49] Safety and effects of a once-weekly, long-acting release formulation of exenatide over 15 weeks in patients with type 2 diabetes
    Maggs, D.
    MacConell, L.
    Zhuang, D.
    Schnabel, C.
    Taylor, K.
    Trautmann, M.
    Kim, D.
    DIABETOLOGIA, 2006, 49 : 3 - 4
  • [50] Efficacy and safety of once-weekly semaglutide vs exenatide ER after 56 weeks in subjects with type 2 diabetes (SUSTAIN 3)
    Ahmann, A.
    Capehom, M.
    Charpentier, G.
    Dotta, E.
    Henkel, E.
    Lingvay, I.
    Holst, A. Gaarsdal
    Annett, M.
    Aroda, V.
    DIABETOLOGIA, 2016, 59 : S76 - S76
12345